AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm issued an overweight rating and a $210.00 target price on the stock. Several other brokerages have also issued reports on ABBV. Truist Financial boosted their price target on AbbVie […]
Cantor Fitzgerald started coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm issued an overweight rating and a $210.00 target price on the stock. Several other brokerages have also issued reports on ABBV. Truist Financial boosted their price target on AbbVie […]
